Ọrịa Crohn (CD) bụ ọrịa na-adịghị ala ala nke na-adịghị akọwapụta nke ọrịa eriri afọ, Etiology nke ọrịa Crohn ka edoghị anya, ugbu a, ọ gụnyere mkpụrụ ndụ ihe nketa, ọrịa, ihe gburugburu ebe obibi na immunologic.

N'ime iri afọ ole na ole gara aga, ọrịa Crohn amụbaala nke ọma.Ebe ọ bụ na e bipụtara mbipụta gara aga nke ntuziaka omume, ọtụtụ mgbanwe ewerewo na nyocha na ọgwụgwọ nke ndị ọrịa nwere ọrịa Crohn.Yabụ na 2018, American Society of Gastroenterology emelitere ntuziaka nke Ọrịa Crohn wee wepụta aro ụfọdụ maka nchoputa na ọgwụgwọ, emebere iji dozie nsogbu ahụike metụtara ọrịa Crohn nke ọma.A na-atụ anya na dọkịta ahụ ga-enwe ike ijikọta ntuziaka na mkpa, ọchịchọ na ụkpụrụ onye ọrịa mgbe ọ na-eme mkpebi ụlọ ọgwụ iji jikwaa ndị ọrịa nwere ọrịa Crohn nke ọma na nke ọma.

Dị ka American Academy of Gastroenteropathy (ACG): Fecal calprotectin (Cal) bụ ihe ngosi ule bara uru, ọ nwere ike inyere aka ịmata ọdịiche dị n'etiti ọrịa bowel na-egbuke egbuke (IBD) na ọrịa obi mgbakasị ahụ (IBS).Na mgbakwunye, ọtụtụ nchọpụta egosila na Fecal calprotectin na-achọpụta IBD na ọrịa cancer colorectal, mmetụta nke ịchọpụta IBD na IBS nwere ike iru 84%-96.6%, nkọwa ahụ nwere ike iru 83%-96.3.

Mara maka yaCalprotectin nke anụ ahụ.